Results 81 to 90 of about 475,313 (268)

Heart failure, dementia is associated with increased stroke severity, in‐hospital mortality and complications

ESC Heart Failure, EarlyView.
Abstract Background Heart failure (HF) is a risk factor for ischemic stroke. Cognitive impairment is very common in HF and stroke patients. Patients with HF have higher risk of developing dementia. However, there are limited studies investigating the characteristics, in‐hospital mortality and complications of stroke patients with both HF and dementia ...
Lijun Zuo, YanHong Dong, Yang Hu, Zixiao Li, Hongqiu Gu, Xingquan Zhao, Yongjun Wang   +6 more
wiley   +1 more source

Thromboembolic and bleeding events in ICU patients with COVID‐19: A nationwide, observational study

Acta Anaesthesiologica Scandinavica, Volume 67, Issue 1, Page 76-85, January 2023., 2023
Abstract Background Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID‐19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID‐19 in Denmark during the first and second waves of the pandemic.
Lene Russell, Sarah Weihe, Emilie Kabel Madsen, Christine Lodberg Hvas, Jens Wolfgang Leistner, Jens Michelsen, Anne Craveiro Brøchner, Anders Bastiansen, Frederik Mølgaard Nielsen, Nick Meier, Anne Sofie Andreasen, Niels‐Erik Ribergaard, Bodil Steen Rasmussen, Christoffer Grant Sølling, David Levarett Buck, Helle Bundgaard, Helle Scharling Pedersen, Iben Strøm Darfelt, Lone Musaeus Poulsen, Michael Ibsen, Ronni R. Plovsing, Sigurdur T. Sigurdsson, Susanne Iversen, Thomas Hildebrandt, Thomas Mohr, Ulrick Skipper Espelund, Vibeke Jørgensen, Nicolai Haase, Anders Perner   +28 more
wiley   +1 more source

A multicentre registry of hospitalized patients with acute and chronic heart failure: Study design of the H2‐registry

ESC Heart Failure, EarlyView.
The H2‐Registry: overview, first results and outlook. Abstract Aims Heart failure (HF) is a highly prevalent condition affecting 1–3% of the adult population in Europe. Despite landmark improvements in HF care over the last two decades, hospitalization and mortality rates remain relatively high.
Johannes Leiner, Sebastian König, Anne Nitsche, Sven Hohenstein, Jana Nagel, Melchior Seyfarth, Henning Baberg, Alexander Lauten, Hans Neuser, Alexander Staudt, Jürgen Tebbenjohanns, René Andrié, Michael Niehaus, Markus W. Ferrari, Ralf Kuhlen, Andreas Bollmann   +15 more
wiley   +1 more source

Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases

British medical journal, 2019
Objective To assess the association between risk of venous thromboembolism and use of different types of hormone replacement therapy. Design Two nested case-control studies.
Y. Vinogradova, C. Coupland, J. Hippisley-Cox   +2 more
semanticscholar   +1 more source

Percutaneous mechanical circulatory support for acute right heart failure: A practical approach

ESC Heart Failure, EarlyView.
This is an overview of percutaneous mechanical circulatory support options for acute right heart failure, illustrating key clinical scenarios, device types, and principles of tailored device selection based on haemodynamics and underlying pathology. Abstract Acute right heart failure (RHF) represents a critical entity with significant morbidity and ...
Mario Gramegna, Christophe Vandenbriele, Guido Tavazzi, Mir B. Basir, Caroline Bleakley, Mario Iannaccone, Daniel Kretzschmar, Francesco Maisano, Anna Mara Scandroglio, Benedikt Schrage, P. Christian Schultze, Gregory Serrao, Matthew Tomey, Richard Trimlett, Dirk Westermann, Matteo Montorfano, George Dangas, Susanna Price, Alaide Chieffo   +18 more
wiley   +1 more source

Oral apixaban for the treatment of acute venous thromboembolism.

New England Journal of Medicine, 2013
BACKGROUND Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify the treatment of venous thromboembolism. METHODS In this randomized, double-blind study, we compared apixaban (at a dose of 10 mg twice daily for 7 days ...
G. Agnelli, H. Buller, A. Cohen, M. Curto, A. Gallus, M. Johnson, Urszula Masiukiewicz, R. Pak, J. Thompson, G. Raskob, J. Weitz   +10 more
semanticscholar   +1 more source

Venous thromboembolism in women [PDF]

Vascular Medicine, 2008
Abstract The risk of venous thromboembolism (VTE) varies throughout a woman’s life and is associated primarily with underlying hormonal exposure. Alteration in hemostatic mechanisms, including resistance to activated protein C, may explain this altered risk.
openaire   +2 more sources

Venous thromboembolism prophylaxis in pregnancy: Are we adequately identifying and managing risks?

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 62, Issue 6, Page 915-920, December 2022., 2022
Pregnancy is a well‐known risk factor of venous thromboembolism. We retrospectively reviewed case histories of 82 pregnant women who developed symptoms of venous pathology, thrombophlebitis, deep vein thrombosis (DVT) or pulmonary embolus (PE) while receiving care at our hospital.
Kay Rui Choy, Shannon Emmett, Audris Wong   +2 more
wiley   +1 more source

Getting square pegs out through round holes: A survey of Australian and New Zealand Gynaecologists regarding specimen retrieval

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 62, Issue 6, Page 894-900, December 2022., 2022
Aims To evaluate morcellation practices among Fellows of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Materials and methods RANZCOG Fellows were invited to complete an online survey. This anonymous, cross‐sectional survey consisted of 29 questions regarding demographics and morcellation practices.
Alison Bryant‐Smith, Jessica Lowe, Alan Lam   +2 more
wiley   +1 more source

Edoxaban for the Treatment of Cancer‐Associated Venous Thromboembolism

New England Journal of Medicine, 2017
Background Low‐molecular‐weight heparin is the standard treatment for cancer‐associated venous thromboembolism. The role of treatment with direct oral anticoagulant agents is unclear. Methods In this open‐label, noninferiority trial, we randomly assigned
G. Raskob, N. van Es, P. Verhamme, M. Carrier, M. Di Nisio, D. Garcia, M. Grosso, Ajay Kakkar, M. Kovacs, M. Mercuri, G. Meyer, A. Segers, M. Shi, Tzu‐Fei Wang, E. Yeo, George Zhang, J. Zwicker, J. Weitz, H. Büller   +18 more
semanticscholar   +1 more source